Achieve life sciences, inc. (ACHV)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
COLLABORATION REVENUE [note 3]

-

-

-

-

18,160

27,116

-

-

-

-

-

COLLABORATION REVENUE (note 3)

-

-

-

-

-

-

29,882

20,095

5,496

13,616

25,539

EXPENSES
Research and development

9,674

5,868

3,101

286

25,108

46,224

55,317

39,948

21,553

18,483

20,209

General and administrative

6,854

6,945

3,531

1,428

11,805

10,625

9,892

7,791

6,230

5,840

3,961

Restructuring costs (recovery) [note 8]

-

-

-

-

-

-267

-

-

-

-

-

Restructuring gain [note 7]

-

-

-

-

-

-

-

-

-

4,038

3,951

Total operating expenses

16,528

12,813

6,632

1,714

36,913

56,582

-

46,082

27,783

28,361

28,121

Restructuring gain

-

-

-

-

-

-

-

1,657

-

-

-

Total operating expenses

-

-

-

-

-

-

65,209

-

-

-

-

OTHER INCOME (EXPENSE)
Interest income

170

171

21

-

119

35

150

292

220

86

47

Bargain purchase gain [note 2]

-

-

1,272

-

-

-

-

-

-

-

-

Contingent value rights recovery [note 2]

-

-

200

-

-

-

-

-

-

-

-

Warrant issuance costs

-

-

-

-

-

531

-

-

-

1,027

-

Gain on warrants

-

-

-150

-

-1,897

-3,741

-3,208

-4,459

-7,388

-96

-

Loss on disposition of intangible asset [note 5]

-

-

-8,610

-

-

-

-

-

-

-

-

Other expenses

-37

-45

-35

-24

-64

-19

120

138

6

6

70

Total other income (expense)

133

126

-7,002

-24

1,952

3,226

3,478

4,889

7,614

-839

117

Net loss before income taxes

-16,395

-12,687

-13,634

-1,738

-

-

-

-

-

-15,584

-2,465

Recovery of deferred income taxes [note 5]

-

-

-3,051

-504

-

-

-

-

-

-

-

Income tax recovery [note 10]

-

-

-

-

-

-

-

-

-

-3,000

3,011

Net loss

-16,395

-12,687

-10,583

-1,234

-16,801

-26,240

-31,849

-21,098

-14,673

-12,584

-

Net unrealized gain on foreign exchange

-

-

-

4

-

-

-

-

-

-

-

Net unrealized gain on securities

-

-

-

-

10

-21

6

1

31

-

-

Total other comprehensive income (loss)

-

-1

-

4

10

-21

6

1

31

-35

-

Net unrealized loss on securities

-

-

-

-

-

-

-

-

-

-35

-

Comprehensive loss

-16,395

-12,687

-10,583

-1,230

-16,791

-26,261

-31,843

-21,097

-14,642

-12,619

-

Net loss attributable to common shareholders

-

-

-

-

-

-

-

-

-

-

-5,476

Basic and diluted net loss per common share

-1.99

-3.61

-22.07

-581.25

-0.64

-1.45

-2.17

-1.56

-1.51

-1.79

-0.95

Weighted average shares used in computation of basic and diluted net loss per common share

8,246

3,510

479

2

26,147

18,098

14,683

13,522

9,729

-

-

Weighted average number of common shares [note 5]

-

-

-

-

-

-

-

-

-

7,030

5,766